Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The debt to equity ratio is N/A as of Tuesday, October 6, 2026.
DEBT TO EQUITY RATIO
N/A
Market Cap
$3.56M
Debt to Equity Ratio
0.00
TTM Avg
0.34
3Y Avg
0.62
5Y Avg
0.44
Market Cap
$3.35M
Debt to Equity Ratio
0.03
TTM Avg
0.53
3Y Avg
0.64
5Y Avg
0.64
Market Cap
$3.23M
Debt to Equity Ratio
4.60
TTM Avg
19.71
3Y Avg
10.03
5Y Avg
6.76
Market Cap
$3.23M
Debt to Equity Ratio
0.14
TTM Avg
0.23
3Y Avg
0.15
5Y Avg
0.15
Market Cap
$3.01M
Debt to Equity Ratio
0.03
TTM Avg
0.03
3Y Avg
0.02
5Y Avg
0.02
Market Cap
$4.02M
Debt to Equity Ratio
N/A
TTM Avg
5.46
3Y Avg
2.73
5Y Avg
1.82
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| YYForce Inc. (YFOR) | $3.47M | N/A | N/A | N/A | N/A |
| Baiya International Group Inc. (BIYA)vs › | $3.56M | 0.00 | 0.34 | 0.62 | 0.44 |
| Addentax Group Corp. (ATXG)vs › | $3.35M | 0.03 | 0.53 | 0.64 | 0.64 |
| INLIF Limited (INLF)vs › | $3.68M | 0.10 | 0.37 | 0.36 | 1.18 |
| Polar Power, Inc. (POLA)vs › | $3.23M | 4.60 | 19.71 | 10.03 | 6.76 |
| Iveda Solutions, Inc. (IVDA)vs › | $3.23M | 0.14 | 0.23 | 0.15 | 0.15 |
| BioNexus Gene Lab Corp. (BGLC)vs › | $3.01M | 0.03 | 0.03 | 0.02 | 0.02 |
| E-Power Inc. Class A (EPOW)vs › | $4.02M | N/A | 5.46 | 2.73 | 1.82 |
| PTL Limited (PTLE)vs › | $2.97M | 0.00 | 0.04 | 0.02 | 0.02 |
| Liberty Defense Holdings, Ltd. Common Shares (DETX)vs › | $4.12M | N/A | N/A | N/A | N/A |
Debt/Equity
N/A
Current Ratio
N/A
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
